Khiron Life Sciences Corp. To Present At The Q1 Virtual Investor Summit
Khiron Life Sciences Corp. (TSXV: KHRN, OTCQX: KHRNF) announced that CEO Alvaro Torres will participate in the Q1 Virtual Investor Summit from March 23-25, 2021. The company's presentation is scheduled for March 24 at 1:00 PM ET. The Investor Summit connects smallcap companies with investors and will feature over 100 companies and 300 institutional and retail investors. Khiron is a leading medical cannabis provider in Colombia and is set to expand its operations into Germany and Brazil this year.
- None.
- None.
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, CEO, will be attending the Q1 Virtual Investor Summit.
| Event | Q1 Investor Summit |
| Date | March 23-25th, 2021 |
| Presentation | March 24th @ 1:00PM ET |
| Location | https://zoom.us/webinar/register/WN_t9RgOzoRRWWAbgaCyaYTaQ |
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at
www.investorsummitgroup.com
Contact:
Brittney Blocker at brittney@investorsummitgroup.com
ABOUT Khiron Life Sciences Corp
Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and is positioned to commence sales of medical cannabis in Germany and Brazil in early 2021.
Leveraging wholly-owned medical clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty. Its Wellbeing unit launched the first branded CBD skincare brand in Colombia, with Kuida™ now marketed in multiple jurisdictions in Latin America, the US and UK. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
Wire Service Contact:
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office
FAQ
When will Khiron Life Sciences participate in the Q1 Virtual Investor Summit?
What date and time is Khiron's presentation at the Investor Summit?
Where can I register for the Q1 Virtual Investor Summit?
What is Khiron Life Sciences known for?
Which countries is Khiron expanding its medical cannabis operations?
